Knobbe Martens Named a California Powerhouse by Law360
Publication highlights firm’s across-the-board strength in intellectual property law IRVINE, Calif., September 24, 2026 – Knobbe Martens is proud to announce that it has been named among Law360’s 2026 California...
FDA Announces New Rare Disease Framework With Potential Implications for IP Strategy
Key Takeaway: On October 14, 2026, the FDA announced a proposed framework for rare disease drug development that aims to provide greater regulatory flexibility and disease-tailored evaluation. Increased regulatory clarity...
Knobbe Martens Earns Multiple Shortlistings at 2026 Financial Times Innovative Lawyers Awards
IRVINE, Calif., October 13, 2026 – Knobbe Martens has been shortlisted as among the country’s most innovative law firms at the 2026 Financial Times Innovative Lawyers North America Awards. The...